Goodwin, P. J., Chen, B. E., Gelmon, K. A., Whelan, T. J., Ennis, M., Lemieux, J., Ligibel, J. A., Hershman, D. L., Mayer, I. A., Hobday, T. J., Bliss, J. M., Rastogi, P., Rabaglio-Poretti, M., Mukherjee, S. D., Mackey, J. R., Abramson, V. G., Oja, C., Wesolowski, R., Thompson, A. M., … Parulekar, W. R. (2022). Effect of Metformin vs Placebo on Invasive Disease–Free Survival in Patients With Breast Cancer. JAMA, 327(20), 1963. https://doi.org/10.1001/jama.2022.6147

Greenlee, H., Iribarren, C., Rana, J. S., Cheng, R., Nguyen-Huynh, M., Rillamas-Sun, E., Shi, Z., Laurent, C. A., Lee, V. S., Roh, J. M., Santiago-Torres, M., Shen, H., Hershman, D. L., Kushi, L. H., Neugebauer, R., & Kwan, M. L. (2022). Risk of Cardiovascular Disease in Women With and Without Breast Cancer: The Pathways Heart Study. Journal of Clinical Oncology, 40(15), 1647–1658. https://doi.org/10.1200/jco.21.01736

Kwan, M. L., Cheng, R. K., Iribarren, C., Neugebauer, R., Rana, J. S., Nguyen-Huynh, M., Shi, Z., Laurent, C. A., Lee, V. S., Roh, J. M., Shen, H., Rillamas-Sun, E., Santiago-Torres, M., Hershman, D. L., Kushi, L. H., & Greenlee, H. (2022). Risk of Cardiometabolic Risk Factors in Women With and Without a History of Breast Cancer: The Pathways Heart Study. Journal of Clinical Oncology, 40(15), 1635–1646. https://doi.org/10.1200/jco.21.01738

Korde, L. A., Somerfield, M. R., & Hershman, D. L. (2022). Use of Immune Checkpoint Inhibitor Pembrolizumab in the Treatment of High-Risk, Early-Stage Triple-Negative Breast Cancer: ASCO Guideline Rapid Recommendation Update. Journal of Clinical Oncology, 40(15), 1696–1698. https://doi.org/10.1200/jco.22.00503

Li, S., Silvestri, V., Leslie, G., Rebbeck, T. R., Neuhausen, S. L., Hopper, J. L., Nielsen, H. R., Lee, A., Yang, X., McGuffog, L., Parsons, M. T., Andrulis, I. L., Arnold, N., Belotti, M., Borg, Å., Buecher, B., Buys, S. S., Caputo, S. M., Chung, W. K., … Antoniou, A. C. (2022). Cancer Risks Associated With BRCA1 and BRCA2 Pathogenic Variants. Journal of Clinical Oncology, 40(14), 1529–1541. https://doi.org/10.1200/jco.21.02112

Lifrieri, A., Fuzesi, S., Desperito, E., & Taback, B. (2022). When the clipped node goes missing, CT guided SAVI SCOUT placement: A novel approach for localizing soft tissue targets. Clinical Imaging, 85, 115–117. https://doi.org/10.1016/j.clinimag.2022.03.003

Pașca, A., Bonci, E.-A., Chiuzan, C., Jiboc, N. M., Gâta, V. A., Muntean, M. V., Matei, I. R., & Achimaș-Cadariu, P. A. (2021). Treatment and Prevention of Periprosthetic Capsular Contracture in Breast Surgery With Prosthesis Using Leukotriene Receptor Antagonists: A Meta-Analysis. Aesthetic Surgery Journal, 42(5), 483–494. https://doi.org/10.1093/asj/sjab355

Vasan, N., & Cantley, L. C. (2022). At a crossroads: how to translate the roles of PI3K in oncogenic and metabolic signalling into improvements in cancer therapy. Nature Reviews Clinical Oncology, 19(7), 471–485. https://doi.org/10.1038/s41571-022-00633-1

Lin, P.-H., Chen, S.-C., Tseng, L.-M., Chang, K.-J., Huang, A.-C., Cheng, K.-C., Yang, K., Wu, H.-C., Chao, T.-Y., Chang, Y.-C., Lin, P.-C., Kuo, W.-H., Kuo, W.-L., Lin, C.-H., Chen, H.-M., Yeh, D.-C., Liu, L.-C., Liu, C.-Y., Wang, M.-Y., … Huang, C.-S. (2022). Impact of BRCA mutation on the survival and risk of contralateral breast cancer in Asian breast cancer patients. Breast Cancer Research and Treatment, 192(3), 629–637. https://doi.org/10.1007/s10549-021-06446-7

Ro, V., McGuinness, J. E., Guo, B., Trivedi, M. S., Jones, T., Chung, W. K., Rao, R., Levinson, E., Koval, C., Russo, D., Chilton, I., Kukafka, R., & Crew, K. D. (2022). Association Between Genetic Testing for Hereditary Breast Cancer and Contralateral Prophylactic Mastectomy Among Multiethnic Women Diagnosed With Early-Stage Breast Cancer. JCO Oncology Practice, 18(4), e472–e483. https://doi.org/10.1200/op.21.00322

Westhoff, C. L., Guo, H., Wang, Z., Hibshoosh, H., Polaneczky, M., Pike, M. C., & Ha, R. (2022). The progesterone-receptor modulator, ulipristal acetate, drastically lowers breast cell proliferation. Breast Cancer Research and Treatment, 192(2), 321–329. https://doi.org/10.1007/s10549-021-06503-1

Pumpalova, Y. S., Ayeni, O. A., Chen, W. C., Buccimazza, I., Cačala, S., Stopforth, L. W., Farrow, H. A., Mapanga, W., Nietz, S., Phakathi, B., Joffe, M., McCormack, V., Jacobson, J. S., Crew, K. D., Neugut, A. I., Ruff, P., Cubasch, H., & O’Neil, D. S. (2022). The Impact of Breast Cancer Treatment Delays on Survival Among South African Women. The Oncologist, 27(3), e233–e243. https://doi.org/10.1093/oncolo/oyab054

Simonds, H. M., & Jacobson, J. S. (2022). Breast cancer survival in women living with HIV. The Lancet HIV, 9(3), e141–e142. https://doi.org/10.1016/s2352-3018(22)00010-8

Rahimi, A., Simmons, A., Kim, D. N., Leitch, M., Haas, J., Gu, X., Ahn, C., Gao, A., Spangler, A., Morgan, H. E., Goudreau, S., Seiler, S., Farr, D., Wooldridge, R., Haley, B., Bahrami, S., Neufeld, S., Mendez, C., Alluri, P., … Timmerman, R. D. (2022). Preliminary Results of Multi-Institutional Phase 1 Dose Escalation Trial Using Single-Fraction Stereotactic Partial Breast Irradiation for Early Stage Breast Cancer. International Journal of Radiation Oncology*Biology*Physics, 112(3), 663–670. https://doi.org/10.1016/j.ijrobp.2021.10.010

Marano, A. A., Grover, K., Peysakhovich, A., Lin, A. J., Castillo, W., & Rohde, C. H. (2022). Comparing Outcomes after Oncoplastic Breast Reduction and Breast Reduction for Benign Macromastia. Plastic & Reconstructive Surgery, 149(3), 541–548. https://doi.org/10.1097/prs.0000000000008822

Acheampong, T., Lee Argov, E. J., Terry, M. B., Rodriguez, C. B., Agovino, M., Wei, Y., Athilat, S., & Tehranifar, P. (2022). Current regular aspirin use and mammographic breast density: a cross-sectional analysis considering concurrent statin and metformin use. Cancer Causes & Control, 33(3), 363–371. https://doi.org/10.1007/s10552-021-01530-1

Dareng, E. O., Tyrer, J. P., Barnes, D. R., Jones, M. R., Yang, X., Aben, K. K. H., Adank, M. A., Agata, S., Andrulis, I. L., Anton-Culver, H., Antonenkova, N. N., Aravantinos, G., Arun, B. K., Augustinsson, A., Balmaña, J., Bandera, E. V., Barkardottir, R. B., Barrowdale, D., Beckmann, M. W., … Pharoah, P. D. P. (2022). Polygenic risk modeling for prediction of epithelial ovarian cancer risk. European Journal of Human Genetics, 30(3), 349–362. https://doi.org/10.1038/s41431-021-00987-7

Ye, Z., Li, S., Dite, G. S., Nguyen, T. L., MacInnis, R. J., Andrulis, I. L., Buys, S. S., Daly, M. B., John, E. M., Kurian, A. W., Genkinger, J. M., Chung, W. K., Phillips, K.-A., Thorne, H., Thorne, H., Winship, I. M., Milne, R. L., Dugué, P.-A., … Hopper, J. L. (2022). Weight is More Informative than Body Mass Index for Predicting Postmenopausal Breast Cancer Risk: Prospective Family Study Cohort (ProF-SC). Cancer Prevention Research, 15(3), 185–191. https://doi.org/10.1158/1940-6207.capr-21-0164

Mullangi, S., & Vasan, N. (2022). Genomic Characterization of De Novo Metastatic Breast Cancer. Clinical Breast Cancer, 22(2), 98–102. https://doi.org/10.1016/j.clbc.2021.11.005

Niehoff, N. M., Terry, M. B., Bookwalter, D. B., Kaufman, J. D., O’Brien, K. M., Sandler, D. P., & White, A. J. (2021). Air Pollution and Breast Cancer: An Examination of Modification By Underlying Familial Breast Cancer Risk. Cancer Epidemiology, Biomarkers & Prevention, 31(2), 422–429. https://doi.org/10.1158/1055-9965.epi-21-1140

Barton, D. L., Pugh, S. L., Ganz, P. A., Plaxe, S. C., Koontz, B. F., Carter, J., Greyz-Yusupov, N., Page, S. J., Rowland, K. M., Balcueva, E. P., Nabeel, S., Basil, J. B., Hill, M. L., Muller, C. Y., Bell, M. C., Deshmukh, S., & Kachnic, L. A. (2022). Randomized Controlled Phase II Evaluation of Two Dose Levels of Bupropion Versus Placebo for Sexual Desire in Female Cancer Survivors: NRG-CC004. Journal of Clinical Oncology, 40(4), 324–334. https://doi.org/10.1200/jco.21.01473

Sharma, R., Louie, A., Thai, C. P., & Dizdarevic, A. (2022). Chest Wall Nerve Blocks for Cardiothoracic, Breast Surgery, and Rib-Related Pain. Current Pain and Headache Reports, 26(1), 43–56. https://doi.org/10.1007/s11916-022-01001-5

Chronister, B. N. C., Wu, T., Santella, R. M., Neugut, A. I., Wolff, M. S., Chen, J., Teitelbaum, S. L., & Parada, H. (2021). Dietary Acid Load, Serum Polychlorinated Biphenyl Levels, and Mortality Following Breast Cancer in the Long Island Breast Cancer Study Project. International Journal of Environmental Research and Public Health, 19(1), 374. https://doi.org/10.3390/ijerph19010374

Plascak, J. J., Rundle, A. G., Xu, X., Mooney, S. J., Schootman, M., Lu, B., Roy, J., Stroup, A. M., & Llanos, A. A. M. (2021). Associations between neighborhood disinvestment and breast cancer outcomes within a populous state registry. Cancer, 128(1), 131–138. Portico. https://doi.org/10.1002/cncr.33900

Li, H., Engel, C., de la Hoya, M., Peterlongo, P., Yannoukakos, D., Livraghi, L., Radice, P., Thomassen, M., Hansen, T. V. O., Gerdes, A.-M., Nielsen, H. R., Caputo, S. M., Zambelli, A., Borg, A., Solano, A., Thomas, A., Parsons, M. T., Antoniou, A. C., Leslie, G., … Goldgar, D. E. (2022). Risks of breast and ovarian cancer for women harboring pathogenic missense variants in BRCA1 and BRCA2 compared with those harboring protein truncating variants. Genetics in Medicine, 24(1), 119–129. https://doi.org/10.1016/j.gim.2021.08.016

Rao, R., McDonald, J. A., Barrett, E. S., Greenberg, P., Teteh, D. K., Montgomery, S. B., Qin, B., Lin, Y., Hong, C.-C., Ambrosone, C. B., Demissie, K., Bandera, E. V., & Llanos, A. A. M. (2022). Associations of hair dye and relaxer use with breast tumor clinicopathologic features: Findings from the Women’s circle of Health Study. Environmental Research, 203, 111863. https://doi.org/10.1016/j.envres.2021.111863

Zhang, X., Wolff, M. S., Shen, J., Parada, H., Santella, R. M., Neugut, A. I., Chen, J., & Teitelbaum, S. L. (2022). Phthalates and Phenols, Leukocyte Telomere Length, and Breast Cancer Risk and Mortality in the Long Island Breast Cancer Study Project. Cancer Epidemiology, Biomarkers & Prevention, 31(1), 117–123. https://doi.org/10.1158/1055-9965.epi-21-0830

SAYAN, M., YEHIA, Z. A., JAN, I., GUPTA, A., VERGALASOVA, I., REVIELLO, M., KUMAR, S., HAFFTY, B., & OHRI, N. (2021). Adaptive Lumpectomy Boost Planning Can Reduce Normal Tissue Exposure in Patients Receiving Hypofractionated Whole Breast Irradiation. Anticancer Research, 42(1), 53–57. https://doi.org/10.21873/anticanres.15456

Weiss, M. C., Hibbs, J. E., Buckley, M. E., Danese, S. R., Leitenberger, A., Bollmann‐Jenkins, M., Meske, S. W., Aliano‐Ruiz, K. E., McHugh, T. W., Larson, S. L., Le, E. H., Green, N. L., Gilman, P. B., Kaklamani, V. G., Chlebowski, R. T., & Martinez, D. M. (2021). A Coala‐T‐Cannabis Survey Study of breast cancer patients’ use of cannabis before, during, and after treatment. Cancer, 128(1), 160–168. Portico. https://doi.org/10.1002/cncr.33906

Kehm, R. D., MacInnis, R. J., John, E. M., Liao, Y., Kurian, A. W., Genkinger, J. M., Knight, J. A., Colonna, S. V., Chung, W. K., Milne, R., Zeinomar, N., Dite, G. S., Southey, M. C., Giles, G. G., McLachlan, S.-A., Whitaker, K. D., Friedlander, M. L., Weideman, P. C., Glendon, G., … Terry, M. B. (2021). Recreational Physical Activity and Outcomes After Breast Cancer in Women at High Familial Risk. JNCI Cancer Spectrum, 5(6). https://doi.org/10.1093/jncics/pkab090

Delahanty, L. M., Wadden, T. A., Goodwin, P. J., Alfano, C. M., Thomson, C. A., Irwin, M. L., Neuhouser, M. L., Crane, T. E., Frank, E., Spears, P. A., Gillis, B. P., Hershman, D. L., Paskett, E. D., Hopkins, J., Bernstein, V., Stearns, V., White, J., Hudis, C., Winer, E. P., … Ligibel, J. A. (2021). The Breast Cancer Weight Loss trial (Alliance A011401): A description and evidence for the lifestyle intervention. Obesity, 30(1), 28–38. Portico. https://doi.org/10.1002/oby.23287

Henry, N. L., Unger, J. M., Till, C., Crew, K. D., Fisch, M. J., & Hershman, D. L. (2021). Predictors of Pain Reduction in Trials of Interventions for Aromatase Inhibitor–Associated Musculoskeletal Symptoms. JNCI Cancer Spectrum, 5(6). https://doi.org/10.1093/jncics/pkab087

Jambhekar, A., Wong, A., Taback, B., Rao, R., Horowitz, D., Connolly, E., & Wiechmann, L. (2021). Complication Rates After Intraoperative Radiation Therapy: Do Applicator Size and Distance to Skin Matter? Journal of Surgical Research, 268, 440–444. https://doi.org/10.1016/j.jss.2021.06.078

Plascak, J. J., Llanos, A. A. M., Mooney, S. J., Rundle, A. G., Qin, B., Lin, Y., Pawlish, K. S., Hong, C.-C., Demissie, K., & Bandera, E. V. (2021). Pathways between objective and perceived neighborhood factors among Black breast cancer survivors. BMC Public Health, 21(1). https://doi.org/10.1186/s12889-021-12057-0

Wu, H.-C., Yang, H.-I., Lin, P.-H., Chen, C.-J., Santella, R. M., & Terry, M. B. (2021). Reproductive and environmental exposures and the breast cancer risk in Taiwanese women. Scientific Reports, 11(1). https://doi.org/10.1038/s41598-021-95290-2

Morra, A., Escala-Garcia, M., Beesley, J., Keeman, R., Canisius, S., Ahearn, T. U., Andrulis, I. L., Anton-Culver, H., Arndt, V., Auer, P. L., Augustinsson, A., Beane Freeman, L. E., Becher, H., Beckmann, M. W., Behrens, S., Bojesen, S. E., Bolla, M. K., Brenner, H., Brüning, T., … Schmidt, M. K. (2021). Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment. Breast Cancer Research, 23(1). https://doi.org/10.1186/s13058-021-01450-7

Leoce, N. M., Jin, Z., Kehm, R. D., Roh, J. M., Laurent, C. A., Kushi, L. H., & Terry, M. B. (2021). Modeling risks of cardiovascular and cancer mortality following a diagnosis of loco-regional breast cancer. Breast Cancer Research, 23(1). https://doi.org/10.1186/s13058-021-01469-w

Valenti, A. B., Wang, M. L., & Otterburn, D. M. (2021). Efficacy of a Single Dose of Peri-Operative Antibiotics in Breast Implant Surgery and Risk Factors for Infection in Post-Mastectomy Patients Undergoing Placement of Permanent Breast Implants. Surgical Infections, 22(9), 968–972. https://doi.org/10.1089/sur.2021.119

Santiago-Torres, M., Contento, I., Koch, P., Tsai, W.-Y., Brickman, A. M., Gaffney, A. O., Thomson, C. A., Crane, T. E., Dominguez, N., Sepulveda, J., Marín-Chollom, A. M., Paul, R., Shi, Z., Ulanday, K. T., Hale, C., Hershman, D., & Greenlee, H. (2021). ¡Mi Vida Saludable! A randomized, controlled, 2 × 2 factorial trial of a diet and physical activity intervention among Latina breast cancer survivors: Study design and methods. Contemporary Clinical Trials, 110, 106524. https://doi.org/10.1016/j.cct.2021.106524

Griffiths, J. I., Chen, J., Cosgrove, P. A., O’Dea, A., Sharma, P., Ma, C., Trivedi, M., Kalinsky, K., Wisinski, K. B., O’Regan, R., Makhoul, I., Spring, L. M., Bardia, A., Adler, F. R., Cohen, A. L., Chang, J. T., Khan, Q. J., & Bild, A. H. (2021). Serial single-cell genomics reveals convergent subclonal evolution of resistance as patients with early-stage breast cancer progress on endocrine plus CDK4/6 therapy. Nature Cancer, 2(6), 658–671. https://doi.org/10.1038/s43018-021-00215-7

Austin, J. D., Allicock, M., Fernandez, M. E., Balasubramanian, B. A., & Lee, S. C. (2021). Understanding the Delivery of Patient-Centered Survivorship Care Planning: An Exploratory Interview Study With Complex Cancer Survivors. Cancer Control, 28. https://doi.org/10.1177/10732748211011957

Farré, P. L., Duca, R. B., Massillo, C., Dalton, G. N., Graña, K. D., Gardner, K., Lacunza, E., & De Siervi, A. (2021). MiR-106b-5p: A Master Regulator of Potential Biomarkers for Breast Cancer Aggressiveness and Prognosis. International Journal of Molecular Sciences, 22(20), 11135. https://doi.org/10.3390/ijms222011135

Saleh, T., El-Sadoni, M., Alhesa, A., Awad, H., Jaradat, M., Al-Hazaimeh, M., Dawoud, R., Mryyian, A., & Azab, B. (2021). Expression of Senescence and Apoptosis Biomarkers in Synchronous Bilateral Breast Cancer: A Case Report. Current Oncology, 28(5), 3836–3845. https://doi.org/10.3390/curroncol28050327

Pellegrino, B., Tommasi, C., Cursio, O. E., Musolino, A., Migliori, E., De Silva, P., Senevirathne, T. H., Schena, M., Scartozzi, M., Farci, D., Willard-Gallo, K., & Solinas, C. (2021). A review of immune checkpoint blockade in breast cancer. Seminars in Oncology, 48(3), 208–225. https://doi.org/10.1053/j.seminoncol.2021.09.002

Fine, R. E., Gilmore, R. C., Dietz, J. R., Boolbol, S. K., Berry, M. P., Han, L. K., Kenler, A. S., Sabel, M., Tomkovich, K. R., VanderWalde, N. A., Chen, M., Columbus, K. S., Curcio, L. D., Feldman, S. M., Gold, L., Hernandez, L., Manahan, E. R., Seedman, S. A., Vaidya, R. P., … Simmons, R. M. (2021). Cryoablation Without Excision for Low-Risk Early-Stage Breast Cancer: 3-Year Interim Analysis of Ipsilateral Breast Tumor Recurrence in the ICE3 Trial. Annals of Surgical Oncology, 28(10), 5525–5534. https://doi.org/10.1245/s10434-021-10501-4

Chow, R., Simone II, C. B., Ro, V., Chiu, L., & Lock, M. (2021). Weight changes of younger and older early breast cancer patients—a meta regression. Annals of Palliative Medicine, 10(10), 10222–10227. https://doi.org/10.21037/apm-21-1650

Goodwin, P. J., Dowling, R. J. O., Ennis, M., Chen, B. E., Parulekar, W. R., Shepherd, L. E., Gelmon, K. A., Whelan, T. J., Ligibel, J. A., Hershman, D. L., Mayer, I. A., Hobday, T. J., Rastogi, P., Rabaglio-Poretti, M., Lemieux, J., Thompson, A. M., Rea, D. W., & Stambolic, V. (2021). Cancer Antigen 15-3/Mucin 1 Levels in CCTG MA.32: A Breast Cancer Randomized Trial of Metformin vs Placebo. JNCI Cancer Spectrum, 5(5). https://doi.org/10.1093/jncics/pkab066

O’Neil, D. S., Nxumalo, S., Ngcamphalala, C., Tharp, G., Jacobson, J. S., Nuwagaba-Biribonwoha, H., Dlamini, X., Pace, L. E., Neugut, A. I., & Harris, T. G. (2021). Breast Cancer Early Detection in Eswatini: Evaluation of a Training Curriculum and Patient Receipt of Recommended Follow-Up Care. JCO Global Oncology, 7, 1349–1357. https://doi.org/10.1200/go.21.00124

Fan, X., Wynn, J., Shang, N., Liu, C., Fedotov, A., Hallquist, M. L. G., Buchanan, A. H., Williams, M. S., Smith, M. E., Hoell, C., Rasmussen-Torvik, L. J., Peterson, J. F., Wiesner, G. L., Murad, A. M., Jarvik, G. P., Gordon, A. S., Rosenthal, E. A., Stanaway, I. B., Crosslin, D. R., … Chung, W. K. (2021). Penetrance of Breast Cancer Susceptibility Genes From the eMERGE III Network. JNCI Cancer Spectrum, 5(4). https://doi.org/10.1093/jncics/pkab044